Payer comparison · CPT Q2057 · TAMPA, FL

Q2057 — Afamitresgene Autoleucel

What each payer pays H Lee Moffitt Cancer Center & Research Institute I (CCN 100271) for this procedure, and where each sits versus the all-payer median at this facility. Find your plan to see whether you're above or below the market here.

$981,450 All-payer median here

$908,750 Cash / self-pay here

14 payer/plan-name variants

← This hospital National rates for Q2057 →

Per-payer negotiated rate at this facility. Use the column headers to sort, the filter row to narrow results.
Payer / plan	Median negotiated	vs all-payer median	Rate rows

MultiPlan	$1,454,000	48.1%	1
EVOLUTIONS HEALTHCARE SYSTEMS	$1,363,125	38.9%	2
UnitedHealthcare	$1,190,462	21.3%	4
Emerging Therapies	$1,090,500	11.1%	1
AvMed	$1,090,500	11.1%	1
Cigna Healthcare	$1,090,500	11.1%	1
Aetna	$1,045,062	6.5%	2
Humana	$936,012	-4.6%	4
Health First	$674,292	-31.3%	2
Devoted Health	$375,132	-61.8%	2
CarePlus (Encounters)	$366,408	-62.7%	1
BayCare Health System, Inc.	$366,408	-62.7%	1
Molina Healthcare	$356,230	-63.7%	1
BlueCross	$348,960	-64.4%	1

Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.